TENX - What's Going On With Tenax Therapeutics Shares? | Benzinga
Tenax Therapeutics, Inc. (NASDAQ:TENX) shares are trading higher by over 10% in the premarket session on Wednesday. The stock gained 31% in yesterday’s regular trading session.
The company said yesterday that U.S. regulators for patents and trademarks allowed its patent application related to its heart failure therapy, levosimendan.
The patent application claims covering the use of TNX-103 (oral levosimendan), TNX-102 (subcutaneous levosimendan), TNX-101 (IV ...